Tiba Aynechi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Menlo Park, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ P. Kent Hawryluk, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Tiba Aynechi

Form 4 holding Director

MBX Biosciences, Inc.

Security class
Common Stock
Shares / value
2,136,335
Estimated value
$22,837,421
Report date
16 Sep 2024
Price
$10.69
Ownership
By Norwest Venture Partners XVI, LP
Form 4 holding Director

Nkarta, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,000
Estimated value
Report date
08 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

MBX Biosciences, Inc.

Security class
Stock option (right to buy)
Shares / value
12,500
Estimated value
Report date
04 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

MBX Biosciences, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
By Norwest Venture Partners XVI, LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Tiba Aynechi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .